比较胸段硬膜外阻滞与椎旁阻滞减少开胸术后慢性疼痛效果的随机对照试验研究方案:TOPIC 2
TOPIC 2是一项多中心、开放标签、平行组、优效性随机对照试验,含内嵌预试验,拟在英国最多20个胸科中心纳入1026例接受开胸术的成人(≥18岁)患者,按1:1随机接受胸段硬膜外阻滞(TEB)或椎旁阻滞(PVB)。主要结局为随机化后6个月慢性术后疼痛发生率,定义为「过去一周最严重胸痛」视觉模拟评分≥40 mm。
要点
- TOPIC 2比较TEB与PVB预防开胸术后慢性疼痛的临床与成本效果。
- 计划纳入1026例成人开胸患者,1:1随机分配至TEB或PVB组。
- 主要结局为随机化后6个月慢性术后疼痛发生率,以视觉模拟评分≥40 mm定义。
核心结论
- TEB与PVB均已被证实可有效预防开胸术后急性疼痛,且全国实践存在分歧;识别哪种镇痛方式在预防慢性开胸术后疼痛方面兼具临床与成本效果,可能减轻慢性疼痛的致残影响、改善健康相关生活质量、促进重返工作和照护职责,并为NHS节省成本。
研究设计与样本
- TOPIC 2为多中心、开放标签、平行组、优效性随机对照试验,含内嵌预试验,在英国最多20个胸科中心纳入1026例接受开胸术的成人(≥18岁)患者,按1:1随机分配至TEB或PVB组。
- 第一年将整合QuinteT(定性研究整合入试验)招募干预(QRI),旨在优化招募和知情同意。
主要发现
- 原文未报告结果。
关键数值与推荐
- 主要结局为随机化后6个月慢性术后疼痛发生率,定义为「过去一周最严重胸痛」视觉模拟评分≥40 mm,提示至少中度疼痛。
- 次要结局包括急性疼痛、区域镇痛和手术并发症、健康相关生活质量、死亡率及健康经济学分析。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Thoracotomy is considered one of the most painful surgical procedures and can cause debilitating chronic post-surgical pain lasting months or years postoperatively. Aggressive management of acute pain resulting from thoracotomy may reduce the likelihood of developing chronic pain. This trial compares the two most commonly used modes of acute analgesia provision at the time of thoracotomy (thoracic epidural blockade (TEB) and paravertebral blockade (PVB)) in terms of their clinical and cost-effectiveness in preventing chronic post-thoracotomy pain. METHODS: TOPIC 2 is a multi-centre, open-label, parallel group, superiority, randomised controlled trial, with an internal pilot investigating the use of TEB and PVB in 1026 adult (≥ 18 years old) patients undergoing thoracotomy in up to 20 thoracic centres throughout the UK. Patients (N = 1026) will be randomised in a 1:1 ratio to receive either TEB or PVB. During the first year, the trial will include an integrated QuinteT (Qualitative Research Integrated into Trials) Recruitment Intervention (QRI) with the aim of optimising recruitment and informed consent. The primary outcome is the incidence of chronic post-surgical pain at 6 months post-randomisation defined as 'worst chest pain over the last week' equating to a visual analogue score greater than or equal to 40 mm indicating at least a moderate level of pain. Secondary outcomes include acute pain, complications of regional analgesia and surgery, health-related quality of life, mortality and a health economic analysis. DISCUSSION: Both TEB and PVB have been demonstrated to be effective in the prevention of acute pain following thoracotomy and nationally practice is divided. Identification of which mode of analgesia is both clinically and cost-effective in preventing chronic post-thoracotomy pain could ameliorate the debilitating effects of chronic pain, improving health-related quality of life, facilitating return to work and caring responsibilities and resulting in a cost saving to the NHS. TRIAL REGISTRATION: NCT03677856 [ClinicalTrials.gov] registered September 19, 2018. https://clinicaltrials.gov/ct2/show/NCT03677856 . First patient recruited 8 January 2019.
引用
- Shelley B, Goebel A, Grant S, et al. Study protocol for a randomised controlled trial to investigate the effectiveness of thoracic epidural and paravertebral blockade in reducing chronic post-thoracotomy pain: 2 (TOPIC 2). Trials. 2023. PMID: 37996898. doi:10.1186/s13063-023-07463-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。